nodes	percent_of_prediction	percent_of_DWPC	metapath
Oritavancin—Induration—Naltrexone—alcohol dependence	0.0532	0.0532	CcSEcCtD
Oritavancin—Tenosynovitis—Citalopram—alcohol dependence	0.0452	0.0452	CcSEcCtD
Oritavancin—Abscess—Acamprosate—alcohol dependence	0.0318	0.0318	CcSEcCtD
Oritavancin—Hyperuricaemia—Acamprosate—alcohol dependence	0.0271	0.0271	CcSEcCtD
Oritavancin—Cellulitis—Naltrexone—alcohol dependence	0.0262	0.0262	CcSEcCtD
Oritavancin—Blood uric acid increased—Acamprosate—alcohol dependence	0.0256	0.0256	CcSEcCtD
Oritavancin—Abscess—Citalopram—alcohol dependence	0.0191	0.0191	CcSEcCtD
Oritavancin—Cellulitis—Citalopram—alcohol dependence	0.0166	0.0166	CcSEcCtD
Oritavancin—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.0164	0.0164	CcSEcCtD
Oritavancin—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.0161	0.0161	CcSEcCtD
Oritavancin—Blood bilirubin increased—Citalopram—alcohol dependence	0.0159	0.0159	CcSEcCtD
Oritavancin—Eosinophilia—Acamprosate—alcohol dependence	0.0156	0.0156	CcSEcCtD
Oritavancin—Aspartate aminotransferase increased—Naltrexone—alcohol dependence	0.0156	0.0156	CcSEcCtD
Oritavancin—Blood uric acid increased—Citalopram—alcohol dependence	0.0154	0.0154	CcSEcCtD
Oritavancin—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.0152	0.0152	CcSEcCtD
Oritavancin—Wheezing—Citalopram—alcohol dependence	0.0146	0.0146	CcSEcCtD
Oritavancin—Infestation NOS—Naltrexone—alcohol dependence	0.0133	0.0133	CcSEcCtD
Oritavancin—Infestation—Naltrexone—alcohol dependence	0.0133	0.0133	CcSEcCtD
Oritavancin—Oedema peripheral—Acamprosate—alcohol dependence	0.0124	0.0124	CcSEcCtD
Oritavancin—Dizziness—Disulfiram—alcohol dependence	0.012	0.012	CcSEcCtD
Oritavancin—Connective tissue disorder—Naltrexone—alcohol dependence	0.0117	0.0117	CcSEcCtD
Oritavancin—Rash—Disulfiram—alcohol dependence	0.0115	0.0115	CcSEcCtD
Oritavancin—Headache—Disulfiram—alcohol dependence	0.0114	0.0114	CcSEcCtD
Oritavancin—Immune system disorder—Acamprosate—alcohol dependence	0.0114	0.0114	CcSEcCtD
Oritavancin—Hypoglycaemia—Citalopram—alcohol dependence	0.0112	0.0112	CcSEcCtD
Oritavancin—Cardiac disorder—Naltrexone—alcohol dependence	0.0111	0.0111	CcSEcCtD
Oritavancin—Malnutrition—Acamprosate—alcohol dependence	0.011	0.011	CcSEcCtD
Oritavancin—Immune system disorder—Naltrexone—alcohol dependence	0.0108	0.0108	CcSEcCtD
Oritavancin—Mediastinal disorder—Naltrexone—alcohol dependence	0.0108	0.0108	CcSEcCtD
Oritavancin—Malnutrition—Naltrexone—alcohol dependence	0.0104	0.0104	CcSEcCtD
Oritavancin—Anaemia—Acamprosate—alcohol dependence	0.0102	0.0102	CcSEcCtD
Oritavancin—Angioedema—Acamprosate—alcohol dependence	0.01	0.01	CcSEcCtD
Oritavancin—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.00985	0.00985	CcSEcCtD
Oritavancin—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.00965	0.00965	CcSEcCtD
Oritavancin—Angioedema—Naltrexone—alcohol dependence	0.0095	0.0095	CcSEcCtD
Oritavancin—Eosinophilia—Citalopram—alcohol dependence	0.00937	0.00937	CcSEcCtD
Oritavancin—Myalgia—Acamprosate—alcohol dependence	0.00936	0.00936	CcSEcCtD
Oritavancin—Bronchospasm—Citalopram—alcohol dependence	0.0093	0.0093	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.0093	0.0093	CcSEcCtD
Oritavancin—Infection—Acamprosate—alcohol dependence	0.00891	0.00891	CcSEcCtD
Oritavancin—Myalgia—Naltrexone—alcohol dependence	0.00886	0.00886	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00879	0.00879	CcSEcCtD
Oritavancin—Tachycardia—Acamprosate—alcohol dependence	0.00876	0.00876	CcSEcCtD
Oritavancin—Skin disorder—Acamprosate—alcohol dependence	0.00872	0.00872	CcSEcCtD
Oritavancin—Infection—Naltrexone—alcohol dependence	0.00843	0.00843	CcSEcCtD
Oritavancin—Infestation NOS—Citalopram—alcohol dependence	0.00843	0.00843	CcSEcCtD
Oritavancin—Infestation—Citalopram—alcohol dependence	0.00843	0.00843	CcSEcCtD
Oritavancin—Nervous system disorder—Naltrexone—alcohol dependence	0.00833	0.00833	CcSEcCtD
Oritavancin—Tachycardia—Naltrexone—alcohol dependence	0.00829	0.00829	CcSEcCtD
Oritavancin—Skin disorder—Naltrexone—alcohol dependence	0.00825	0.00825	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.00817	0.00817	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.00775	0.00775	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.00773	0.00773	CcSEcCtD
Oritavancin—Oedema peripheral—Citalopram—alcohol dependence	0.00746	0.00746	CcSEcCtD
Oritavancin—Connective tissue disorder—Citalopram—alcohol dependence	0.00744	0.00744	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.00733	0.00733	CcSEcCtD
Oritavancin—Erythema multiforme—Citalopram—alcohol dependence	0.00716	0.00716	CcSEcCtD
Oritavancin—Urticaria—Acamprosate—alcohol dependence	0.00713	0.00713	CcSEcCtD
Oritavancin—Cardiac disorder—Citalopram—alcohol dependence	0.00703	0.00703	CcSEcCtD
Oritavancin—Immune system disorder—Citalopram—alcohol dependence	0.00684	0.00684	CcSEcCtD
Oritavancin—Mediastinal disorder—Citalopram—alcohol dependence	0.00682	0.00682	CcSEcCtD
Oritavancin—Urticaria—Naltrexone—alcohol dependence	0.00674	0.00674	CcSEcCtD
Oritavancin—Hypersensitivity—Acamprosate—alcohol dependence	0.00661	0.00661	CcSEcCtD
Oritavancin—Malnutrition—Citalopram—alcohol dependence	0.00659	0.00659	CcSEcCtD
Oritavancin—Pruritus—Acamprosate—alcohol dependence	0.00635	0.00635	CcSEcCtD
Oritavancin—Hypersensitivity—Naltrexone—alcohol dependence	0.00625	0.00625	CcSEcCtD
Oritavancin—Diarrhoea—Acamprosate—alcohol dependence	0.00614	0.00614	CcSEcCtD
Oritavancin—Anaemia—Citalopram—alcohol dependence	0.00609	0.00609	CcSEcCtD
Oritavancin—Angioedema—Citalopram—alcohol dependence	0.00602	0.00602	CcSEcCtD
Oritavancin—Pruritus—Naltrexone—alcohol dependence	0.00601	0.00601	CcSEcCtD
Oritavancin—Dizziness—Acamprosate—alcohol dependence	0.00593	0.00593	CcSEcCtD
Oritavancin—Diarrhoea—Naltrexone—alcohol dependence	0.00581	0.00581	CcSEcCtD
Oritavancin—Vomiting—Acamprosate—alcohol dependence	0.0057	0.0057	CcSEcCtD
Oritavancin—Rash—Acamprosate—alcohol dependence	0.00566	0.00566	CcSEcCtD
Oritavancin—Dermatitis—Acamprosate—alcohol dependence	0.00565	0.00565	CcSEcCtD
Oritavancin—Headache—Acamprosate—alcohol dependence	0.00562	0.00562	CcSEcCtD
Oritavancin—Dizziness—Naltrexone—alcohol dependence	0.00561	0.00561	CcSEcCtD
Oritavancin—Myalgia—Citalopram—alcohol dependence	0.00561	0.00561	CcSEcCtD
Oritavancin—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.00557	0.00557	CcSEcCtD
Oritavancin—Vomiting—Naltrexone—alcohol dependence	0.0054	0.0054	CcSEcCtD
Oritavancin—Rash—Naltrexone—alcohol dependence	0.00535	0.00535	CcSEcCtD
Oritavancin—Dermatitis—Naltrexone—alcohol dependence	0.00535	0.00535	CcSEcCtD
Oritavancin—Infection—Citalopram—alcohol dependence	0.00534	0.00534	CcSEcCtD
Oritavancin—Nausea—Acamprosate—alcohol dependence	0.00533	0.00533	CcSEcCtD
Oritavancin—Headache—Naltrexone—alcohol dependence	0.00532	0.00532	CcSEcCtD
Oritavancin—Nervous system disorder—Citalopram—alcohol dependence	0.00527	0.00527	CcSEcCtD
Oritavancin—Tachycardia—Citalopram—alcohol dependence	0.00525	0.00525	CcSEcCtD
Oritavancin—Skin disorder—Citalopram—alcohol dependence	0.00522	0.00522	CcSEcCtD
Oritavancin—Nausea—Naltrexone—alcohol dependence	0.00504	0.00504	CcSEcCtD
Oritavancin—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.0049	0.0049	CcSEcCtD
Oritavancin—Gastrointestinal disorder—Citalopram—alcohol dependence	0.00464	0.00464	CcSEcCtD
Oritavancin—Urticaria—Citalopram—alcohol dependence	0.00427	0.00427	CcSEcCtD
Oritavancin—Hypersensitivity—Citalopram—alcohol dependence	0.00396	0.00396	CcSEcCtD
Oritavancin—Pruritus—Citalopram—alcohol dependence	0.00381	0.00381	CcSEcCtD
Oritavancin—Diarrhoea—Citalopram—alcohol dependence	0.00368	0.00368	CcSEcCtD
Oritavancin—Dizziness—Citalopram—alcohol dependence	0.00356	0.00356	CcSEcCtD
Oritavancin—Vomiting—Citalopram—alcohol dependence	0.00342	0.00342	CcSEcCtD
Oritavancin—Rash—Citalopram—alcohol dependence	0.00339	0.00339	CcSEcCtD
Oritavancin—Dermatitis—Citalopram—alcohol dependence	0.00339	0.00339	CcSEcCtD
Oritavancin—Headache—Citalopram—alcohol dependence	0.00337	0.00337	CcSEcCtD
Oritavancin—Nausea—Citalopram—alcohol dependence	0.0032	0.0032	CcSEcCtD
